The attached paper outlines the position of the International Association of Mutual Benefit Societies (AIM) on the Critical Medicines Act and its potential impact on healthcare access and affordability as well as the role of solidarity based, not-for-profit health insurers and mutuals thereon.
IAM
International Association of Mutual Benefits
NGO · Belgium
not in the EU Transparency RegisterThis organization files on consultations without a register number, so its record here is built from its filings alone. Register facts (staff, costs, accreditations) are not available for it.
2
positions filed
in the 673 files tracked
1
legislative file
of 673 tracked
2
with a full position paper
attached to a submission
Counts here are a floor, never a total: they cover the 673 consultation files tracked so far (58,314 submissions, mostly 2021–26), so an organization's real filing history is larger, not smaller.
Track International in PolicySpeak: request access →
Work at International Association of Mutual Benefits? so we know who speaks for it.
Their record over time
International Association of Mutual Benefits filed 2 positions between 27 Feb 2025 and 24 Jun 2025, across 1 of the 673 legislative files tracked here, attaching a full position paper 2 times.
What they argued
The International Association of Mutual Benefit Societies (AIM) welcomes the potential implementation of a Critical Medicines Act as a crucial step toward ensuring equitable access to medicines across Member States. While innovation is important, the Act should primarily focus on addressing shortages, which mainly affect off-patent medicines.
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Put International Association of Mutual Benefits next to another organization. Same files, same register facts, side by side. Compare →
Is this your organization?
Everything on this page comes from International Association of Mutual Benefits’s own submissions to the European Commission. We have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.